Facebook
Google+
LinkedIn
Educational Events & Programs
DATES > Friday, October 6 – Saturday, October 7, 2017 LEARN MORE>
LOCATION > Hilton San Francisco Union Square • San Francisco, California
Additional Programs:
Save the Date!
NCCN Global Academy > Friday, October 6, 2017 LEARN MORE>
New Program for Nurses!
NCCN Nursing Forum: Advancing Oncology Nursing in Hematologic Malignancies™ > Friday, October 6, 2017 LEARN MORE>
Early bird registration discount ends on Friday, August 25!
Overview
Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.
Co-Chairs:
Ranjana H. Advani, MD
Stanford Cancer Institute
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
Agenda*
Friday, October 6, 2017
4:30 PM |
Registration Desk Opens |
4:30 - 6:00 PM |
Refreshments and Exhibits |
| 6:00 - 6:15 PM |
Opening Remarks
Ranjana H. Advani, MD
Stanford Cancer Institute
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center |
| 6:15 - 6:40 PM |
WHO Classification of Lymphoma: A Clinician’s Perspective
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center |
| 6:45 - 7:10 PM |
Updates on the Treatment of Follicular Lymphoma
Jane N. Winter, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University |
| 7:15 - 7:40 PM |
New Options for the Management of Hodgkin Lymphoma
Ranjana H. Advani, MD
Stanford Cancer Institute |
| 7:45 - 8:35 PM |
Patient Case Studies and Panel Discussion: Lymphoma
Moderator:
Ranjana H. Advani, MD
Stanford Cancer Institute
Panelists:
Mark W. Clemens, II, MD
The University of Texas MD Anderson Cancer Center
Youn H. Kim, MD
Stanford Cancer Institute
Jane N. Winter, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center |
Saturday, October 7, 2017
7:00 - 8:00 AM |
Breakfast and Exhibits |
8:00 - 8:05 AM |
Opening Remarks
Ranjana H. Advani, MD
Stanford Cancer Institute
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center |
| 8:05 - 8:45 AM |
Managing Lymphoma Survivors
Sharyn L. Kurtz, PA-C, MPAS, MA
Dana-Farber/Brigham and Women's Cancer CenterMassachusetts General Hospital Cancer Center |
| 8:50 - 9:40 AM |
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms
Moderator:
Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center
Panelists:
Natalie S. Callander, MD
University of Wisconsin Carbone Cancer Center
Shaji K. Kumar, MD
Mayo Clinic Cancer Center
Jeffrey Wolf, MD
UCSF Helen Diller Family Comprehensive Cancer Center |
| 9:45 - 10:10 AM |
Management of Newly Diagnosed Multiple Myeloma in Those Eligible for Transplant
Shaji K. Kumar, MD
Mayo Clinic Cancer Center |
| 10:10 - 10:40 AM |
Break and Exhibits |
| 10:40 - 11:05 AM |
Treatment of Relapsed/Refractory Multiple Myeloma
Natalie S. Callander, MD
University of Wisconsin Carbone Cancer Center |
| 11:10 - 11:35 AM |
Management of Common Complications Related to Multiple Myeloma and its Treatment
Kathleen Colson, RN, BSN, BS
Dana-Farber/Brigham and Women’s Cancer Center
Massachusetts General Hospital Cancer Center |
| 11:40 - 12:05 PM |
Palliative and End of Life Care in Hematological Malignancies
Thomas W. LeBlanc, MD, MA
Duke Cancer Institute |
| 12:05 - 1:05 PM |
Lunch and Exhibits |
| 1:05 - 1:55 PM |
Patient Case Studies and Panel Discussion: Leukemia
Moderator:
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center
Panelists:
Ruben A. Mesa, MD
Mayo Clinic Cancer Center
Neil P. Shah, MD, PhD
UCSF Helen Diller Family Comprehensive Cancer Center
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center |
| 2:00 - 2:25 PM |
Myeloproliferative Neoplasms:
Management of Polycythemia Vera and Essential Thrombocythemia
Ruben A. Mesa, MD
Mayo Clinic Cancer Center |
| 2:30 - 2:55 PM |
How to Sequence Therapy in Chronic Lymphocytic Leukemia
William G. Wierda, MD, PhD
The University of Texas MD Anderson Cancer Center |
| 3:00 - 3:25 PM |
New Therapeutic Agents and Considerations in the
Management of Acute Lymphocytic Leukemia
David G. Maloney, MD, PhD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance |
| 3:25 - 3:50 PM |
Break and Exhibits |
| 3:50 - 4:15 PM |
Targeted Therapy for Acute Myeloid Leukemia
Bruno C. Medeiros, MD
Stanford Cancer Institute |
| 4:20 - 5:00 PM |
Controversies in Acute Myeloid Leukemia:
Is Monitoring Minimal Residual Disease Clinically Relevant?
Jessica K. Altman, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Richard M. Stone, MD
Dana-Farber Cancer Institute |
| 5:00 PM |
Closing Remarks
Ranjana H. Advani, MD
Stanford Cancer Institute
Andrew D. Zelenetz, MD, PhD
Memorial Sloan Kettering Cancer Center |
Last updated June 21, 2017
*This agenda is subject to change. Faculty will be updated as confirmed.
Accreditation
This program has been approved for AMA PRA Category 1 Credit™ and ABIM MOC for physicians and will award contact hours for nurses, pharmacists, and other health care professionals. Learn more.
Intended Audience
This congress is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Fees
Reserve your seat by Friday, August 25 to receive the Early Bird Discount. As a benefit of membership, NCCN extends a 50% discount off the registration fee to staff employed at NCCN Member Institutions. Complimentary registration is available for Residents, Fellows, and Junior Faculty at NCCN Member Institutions. Please contact conferences@nccn.org to learn how to apply this discount. Learn more.
Fellows and Residents Requirement
Fellows and Residents must provide a letter on institution letterhead from their Director stating that they are in good standing. Learn more.
Accommodations
NCCN has a limited number of rooms reserved for registered attendees for the nights of Friday, October 6 and Saturday, October 7 at a discounted rate of $269 per night. Please book your room by Tuesday, September 5 to take advantage of this special rate. Early booking is strongly encouraged. Learn more.
Supporter Opportunities
Organizations who are interested in supporting NCCN CE programs are encouraged to contact Lisa Perfidio.
Sponsorship and exhibit opportunities are available. For more information, contact Jennifer Tredwell.
EXHIBITOR INFORMATION
NCCN 12th Annual Congress: Hematologic Malignancies™ - Sponsor and Exhibitor Prospectus
NCCN 12th Annual Congress: Hematologic Malignancies™ - Advertising Rate Card
Recorded Presentations
Earn up to 8.75 credits with recorded presentations from the NCCN 11th Annual Congress: Hematologic Malignancies™ that took place September 30 - October 1, 2016 in New York, NY.
Recorded Lunch Symposium – The Future of Targeted Therapies for Acute Myeloid Leukemia
Earn .75 credit! This activity is designed to address the unprecedented recent and ongoing advances in AML research and anticipated changes in the AML therapeutic landscape resulting from the development of many innovative therapies, several of which are in late stages of clinical trials.
For a complete list of available recordings from the NCCN 11th Annual Congress: Hematologic Malignancies, please visit education.nccn.org/hem2016.
Future Congress Dates
NCCN 13th Annual Congress: Hematologic Malignancies™
Friday, September 21 – Saturday, September 22, 2018
New York Marriott Marquis ǀ New York, New York
Please check back often for the most up-to-date information. Please contact 866.788.NCCN (6226) or send an e-mail if you have additional questions.